[SGMO] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[SGMO] Sangamo Therapeutics, Inc.
Announcement Date
28-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- 116.68%
YoY- 124.41%
Quarter Report
SGMO's Result
SGMO's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 27,230 27,986 25,800 54,851 26,837 13,077 8,922 20.42%
PBT -51,714 -37,563 -40,567 4,501 -19,219 -13,091 -9,611 32.35%
Tax 259 -67 108 179 -1,246 -468 13 64.61%
NP -51,973 -37,496 -40,604 4,555 -18,664 -13,091 -9,624 32.43%
Tax Rate - - - -3.98% - - - -
Total Cost 79,203 65,482 66,404 50,296 45,501 26,168 18,546 27.36%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -190.87 -133.98 -157.38 8.30 -69.55 -100.11 -107.87 9.97%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.32 -0.26 -0.29 0.04 -0.18 -0.15 -0.14 14.76%
EPS Diluted -0.32 -0.26 -0.29 0.04 -0.18 -0.15 -0.14 14.76%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.